1248 Management’s AstraZeneca AZN Stock Holding History

1248 Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$587K	Buy	2,976 +2,915	+4,779%	+$562K	0.27%	54
2025 Q4	$11.2K	Hold	61	–	–	0.01%	143
2025 Q3	$9.36K	Hold	61	–	–	0.01%	144
2025 Q2	$8.53K	Buy	61 +26	+74%	+$3.64K	﹤0.01%	159
2025 Q1	$5.14K	Buy	+35	New	+$5.06K	﹤0.01%	167

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

1248 Management's AZN Position: Q1 2026 in Review

1248 Management increased its AstraZeneca (AZN) stake by 4,779% in Q1 2026, buying an estimated $562K and bringing the position to 2,976 shares worth $587K. The position accounts for 0.27% of the portfolio, ranked #54.

1248 Management first reported a position in AZN in Q1 2025 and has held it in 5 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

1248 Management held 2,976 shares of AstraZeneca worth $587K as of Q1 2026.
1248 Management bought 2,915 AstraZeneca shares in Q1 2026, an estimated $562K.
AstraZeneca made up 0.27% of 1248 Management's portfolio in Q1 2026, its #54 holding.
1248 Management first reported a position in AstraZeneca in Q1 2025 and has held it in 5 quarters since.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on 1248 Management's 13F filing for Q1 2026, filed 15 May 2026.